SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
210 hedge funds and large institutions have $1.65B invested in Sage Therapeutics in 2022 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 70 increasing their positions, 73 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 36
2% less funds holding
Funds holding: 215 → 210 (-5)
22% less capital invested
Capital invested by funds: $2.12B → $1.65B (-$466M)
Holders
210
Holding in Top 10
2
Calls
$26.8M
Puts
$23.6M
Top Buyers
| 1 | +$24.6M | |
| 2 | +$22.1M | |
| 3 | +$19.8M | |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$12.3M |
| 5 |
Morgan Stanley
New York
|
+$9.15M |
Top Sellers
| 1 | -$40M | |
| 2 | -$32.8M | |
| 3 | -$13.8M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$9.15M |
| 5 |
AG
Artal Group
Luxembourg
|
-$8.28M |